Showing results (481-490 of 625) with videos related to
Sort By:
Pageof 63
Plos One|October 8, 2013
Tn6188 - a novel transposon in Listeria monocytogenes responsible for tolerance to benzalkonium chlorideAnneliese Müller, Kathrin Rychli, Meryem Muhterem-Uyar, et al.Kidney & Blood Pressure Research|July 28, 2017
TIMP-2*IGFBP7 (Nephrocheck®) Measurements at Intensive Care Unit Admission After Cardiac Surgery are Predictive for Acute Kidney Injury Within 48 HoursMehmet Oezkur, Attila Magyar, Phillip Thomas, et al.Gastroenterology|June 11, 2002
Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cellsMartin Wagner, Christoph K Weber, Frank Bressau, et al.BMC Genomics|December 1, 2020
Virulence characterization and comparative genomics of Listeria monocytogenes sequence type 155 strainsEva Wagner, Andreas Zaiser, Rebekka Leitner, et al.Journal of Visualized Experiments : Jove|September 6, 2017
Intravital Microscopy of Monocyte Homing and Tumor-Related Angiogenesis in a Murine Model of Peripheral Arterial DiseaseMartin Wagner, Claudia Baer, Werner Zuschratter, et al.NPJ Science of Food|May 19, 2025
The type of food influences the behaviour of Listeria monocytogenes in a food-gastrointestinal-infection modelNadja Pracser, Andreas Zaiser, Luminita Ciolacu, et al.Human Molecular Genetics|September 24, 2010
K14 mRNA reprogramming for dominant epidermolysis bullosa simplexVerena Wally, Marietta Brunner, Thomas Lettner, et al.Meat Science|November 25, 2015
Dynamics of Listeria monocytogenes colonisation in a newly-opened meat processing facilityAndrei Sorin Bolocan, Anca Ioana Nicolau, Avelino Alvarez-Ordóñez, et al.International Journal of Computer Assisted Radiology and Surgery|May 5, 2016
Robust near real-time estimation of physiological parameters from megapixel multispectral images with inverse Monte Carlo and random forest regressionSebastian J Wirkert, Hannes Kenngott, Benjamin Mayer, et al.The Lancet. Gastroenterology & Hepatology|July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trialStefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.Pageof 63